Aligos Therapeutics, Inc. 10-Q filing
Filed 2025-08-06 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-104042
- Form type
- 10-Q
- CIK
- 0001799448
- Primary document
- https://www.sec.gov/Archives/edgar/data/1799448/000095017025104042/algs-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aligos Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $1.3M | - | - |
| Operating Income | $-37.8M | - | - |
| Net Income | $27.2M | - | - |
| Eps Basic | 2.9 | - | - |
| Eps Diluted | 2.9 | - | - |
| Cash And Equivalents | $18.7M | - | - |
| Total Assets | $134.7M | - | - |
| Total Liabilities | $32.8M | - | - |
| Shareholders Equity | $101.9M | - | - |
| Operating Cash Flow | $-36.4M | - | - |